Reach Us. +44 1223 790975
Citations Report - Journal of Alzheimers Disease and Parkinsonism | 39

ºÚÁÏÍø

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
ºÚÁÏÍø

Like us on:

organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 3123

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.

Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.

  2023 2022 2021 2020 2019 2018 2017 2016

Total published articles

26 33 60 35 45 44 107 89

Conference proceedings

0 33 0 0 82 213 118 158

Citations received as per Google Scholar, other indexing platforms and portals

123 389 489 425 374 263 237 253
Journal total citations count 3123
Journal impact factor 2.04
Journal 5 years impact factor 3.14
Journal cite score 10.01
Journal h-index 25
Journal h-index since 2019 22
image

Cannabinoid CB 2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells

  | |
image

Role of MSK1 in the induction of NF-?B by the chemokine CX3CL1 in microglial cells

  | |
image

Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease

  | |
image

CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies

  | |
image

Optimization of vinyl sulfone derivatives as potent nuclear factor erythroid 2-related factor 2 (Nrf2) activators for Parkinson's disease therapy

  | |
image

Basic concepts on the role of nuclear factor erythroid-derived 2-like 2 (Nrf2) in age-related diseases

  | |
image

Cx3cr1?deficiency exacerbates alpha?synuclein?A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease

  | |
image

Nrf2/ARE pathway modulation by dietary energy regulation in neurological disorders

  | |
image

The anti-inflammatory and anti-oxidant mechanisms of the Keap1/Nrf2/ARE signaling pathway in chronic diseases

  | |
image

TFEB protein expression is reduced in aged brains and its overexpression mitigates senescence-associated biomarkers and memory deficits in mice

  | |
image

A novel transgenic zebrafish line allows for in vivo quantification of autophagic activity in neurons

  | |
image

Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy in vivo

  | |
image

DNAzyme-Based Lithium-Selective Imaging Reveals Higher Lithium Accumulation in Bipolar Disorder Patient-Derived Neurons

  | |
image

Clinical and imaging correlates of Impaired cerebral vasoreactivity in patients with Parkinson's disease

  View at Publisher | View at Google Scholar |
image

Cerebral Vasoreactivity Changes Over Time in Patients With Different Clinical Manifestations of Cerebral Small Vessel Disease

  | |
image

Ultrasonographic Changes in Brain Hemodynamics in Patients with Parkinson's Disease and Risk Factors for Cerebrovascular Disease: A Pilot Study

  | |
image

With great interest we read the article recently published by Dadar and colleagues1 in Movement Disorders Clinical Practice. They report that in patients with early untreated de novo Parkinson’s disease (PD), the interplay between dysautonomia and the burden of white matter hyperintensities (WMH) results in pronounced and accelerated cognitive decline. Although their results are of critical significance to help understand pathophysiological changes underlying cognitive decline and to address dysautonomia as a potential therapeutic target, we consider that there is 1 situation that has remained understudied in PD: cerebral vasomotor reactivity (CVR).

  | |
image

The renaissance of heart rate variability as a predictor of cognitive functioning

  | |
image

Potential clinical utility of multiple system atrophy biomarkers

  | |
image

Lipid Metabolism in Neurocognitive Disorders: Current Update

  | |

Contact Us

Agri and Aquaculture Journals

Dr. Krish

agriaquaculture@omicsonline.com

+1-702-714-7001Extn: 9040

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemistryjournals@omicsonline.com

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinicaljournals@omicsonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjournals@omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

generalscience@omicsonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

geneticsmolbio@omicsonline.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrobiol@omicsonline.com

1-702-714-7001Extn: 9014

Nursing & Health Care Journals

Stephanie Skinner

nursinghealthcare@omicsonline.com

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljournals@omicsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

pharmajournals@omicsonline.com

1-702-714-7001Extn: 9007

 
© 2008- 2024 - ºÚÁÏÍø. Best viewed in | |